Intratumoral injection of a CpG oligonucleotide reverts resistance to PD-1 blockade by expanding multifunctional CD8+ T cells
Wanga et al.
Papers
PNAS
September 2016
Authors and Affiliates
Shu Wanga, Jose Camposa, Marilena Gallotta, Mei Gong, Chad Crain, Edwina Naik, Robert L. Coffmana, and Cristiana Guiducci
Discovery, Dynavax Technologies Corporation, Berkeley, CA 94710
